COMMUNIQUÉS West-GlobeNewswire
-
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
03/03/2026 -
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
03/03/2026 -
ATI Advisory Welcomes Former Wisconsin Medicaid Director Bill Hanna as Practice Director of Payer Strategy and Program Design
03/03/2026 -
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting
03/03/2026 -
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2026 -
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
03/03/2026 -
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
03/03/2026 -
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
03/03/2026 -
Résultats 2025 : amélioration de la marge de Core EBITDA en dépit de vents contraires sur l’activité, grâce à une stricte discipline financière
03/03/2026 -
TimelyCare Honored as Virtual Student Health and Wellness Services Company of the Year 2026 by Education Insider
03/03/2026 -
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
03/03/2026 -
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
03/03/2026 -
Suzanne Nora Johnson Joins Wellcome Leap Board of Directors
03/03/2026 -
Sympathiq Launches Well-Being Marketplace Connecting UK Residents with Certified Mental Health Specialists
03/03/2026 -
2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03/2026 -
Testosterone Booster Supplement for Men Over 50 — TestoPrime Medically Accredited by Clinicians' Choice in 2026
03/03/2026 -
Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology
03/03/2026 -
Exagen Inc. to Participate in Upcoming Investor Conferences
03/03/2026 -
PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders
03/03/2026
Pages